Full metadata record

DC Field Value Language
dc.contributor.authorYoo, Wonbeak-
dc.contributor.authorLee, Wonhwa-
dc.contributor.authorKim, Hong Nam-
dc.contributor.authorJeong, Jiyoung-
dc.contributor.authorPark, Hee Ho-
dc.contributor.authorAhn, June Hong-
dc.contributor.authorJung, Dana-
dc.contributor.authorLee, Juheon-
dc.contributor.authorKim, Ji-su-
dc.contributor.authorLee, Seung Whan-
dc.contributor.authorCho, Wan-Seob-
dc.contributor.authorKim, Seokho-
dc.date.accessioned2024-01-19T12:04:17Z-
dc.date.available2024-01-19T12:04:17Z-
dc.date.created2022-05-12-
dc.date.issued2022-04-
dc.identifier.issn2296-4185-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/115299-
dc.description.abstractCytokine release syndrome (CRS) is a systemic inflammatory response resulting in overexpression of cytokines in serum and tissues, which leads to multiple-organ failure. Due to rapid aggravation of symptoms, timely intervention is paramount; however, current therapies are limited in their capacity to address CRS. Here, we find that the intravenous injection of highly purified detonation-synthesized nanodiamonds (DND) can act as a therapeutic agent for treating CRS by adsorbing inflammatory cytokines. Highly purified DNDs successfully inactivated various key cytokines in plasma from CRS patients with pneumonia, septic shock, and coronavirus disease 2019 pandemic (COVID-19). The intravenous injection of the DND samples in a mouse sepsis model by cecal ligation and puncture significantly improved survival rates and prevented tissue damage by reducing the circulating inflammatory cytokines. The results of this study suggest that the clinical application of highly purified DND can provide survival benefits for CRS patients by adsorbing inflammatory cytokines.-
dc.languageEnglish-
dc.publisherFrontiers Research Foundation-
dc.titleNanodiamond as a Cytokine Sponge in Infectious Diseases-
dc.typeArticle-
dc.identifier.doi10.3389/fbioe.2022.862495-
dc.description.journalClass1-
dc.identifier.bibliographicCitationFrontiers in Bioengineering and Biotechnology, v.10-
dc.citation.titleFrontiers in Bioengineering and Biotechnology-
dc.citation.volume10-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000788680500001-
dc.relation.journalWebOfScienceCategoryBiotechnology & Applied Microbiology-
dc.relation.journalWebOfScienceCategoryMultidisciplinary Sciences-
dc.relation.journalResearchAreaBiotechnology & Applied Microbiology-
dc.relation.journalResearchAreaScience & Technology - Other Topics-
dc.type.docTypeArticle-
dc.subject.keywordPlusCARBIDE-DERIVED CARBON-
dc.subject.keywordPlusSEPSIS-
dc.subject.keywordPlusADSORPTION-
dc.subject.keywordPlusNANOPARTICLES-
dc.subject.keywordPlusBLOCKADE-
dc.subject.keywordPlusREMOVAL-
dc.subject.keywordPlusSTORM-
dc.subject.keywordAuthornanodiamond-
dc.subject.keywordAuthorcytokine release syndrome-
dc.subject.keywordAuthoradsorption-
dc.subject.keywordAuthorinfectious diseases-
dc.subject.keywordAuthormultiple-organ failure-
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE